These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28298083)

  • 1. Alpha-Synuclein Disease Mutations Are Structurally Defective and Locally Affect Membrane Binding.
    Robotta M; Cattani J; Martins JC; Subramaniam V; Drescher M
    J Am Chem Soc; 2017 Mar; 139(12):4254-4257. PubMed ID: 28298083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson's disease revealed by solution NMR spectroscopy.
    Bodner CR; Maltsev AS; Dobson CM; Bax A
    Biochemistry; 2010 Feb; 49(5):862-71. PubMed ID: 20041693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruptive membrane interactions of alpha-synuclein aggregates.
    Iyer A; Claessens MMAE
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):468-482. PubMed ID: 30315896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cu2+ binding modes of recombinant alpha-synuclein--insights from EPR spectroscopy.
    Drew SC; Leong SL; Pham CL; Tew DJ; Masters CL; Miles LA; Cappai R; Barnham KJ
    J Am Chem Soc; 2008 Jun; 130(24):7766-73. PubMed ID: 18494470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing.
    van Rooijen BD; Claessens MM; Subramaniam V
    FEBS Lett; 2008 Nov; 582(27):3788-92. PubMed ID: 18930058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The newly discovered Parkinson's disease associated Finnish mutation (A53E) attenuates α-synuclein aggregation and membrane binding.
    Ghosh D; Sahay S; Ranjan P; Salot S; Mohite GM; Singh PK; Dwivedi S; Carvalho E; Banerjee R; Kumar A; Maji SK
    Biochemistry; 2014 Oct; 53(41):6419-21. PubMed ID: 25268550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of lipid vesicles into cylindrical micelles by α-synuclein in an extended α-helical conformation.
    Mizuno N; Varkey J; Kegulian NC; Hegde BG; Cheng N; Langen R; Steven AC
    J Biol Chem; 2012 Aug; 287(35):29301-11. PubMed ID: 22767608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing Alpha-Synuclein Conformations by Electron Paramagnetic Resonance (EPR) Spectroscopy.
    Cattani J; Braun T; Drescher M
    Methods Mol Biol; 2019; 1948():247-260. PubMed ID: 30771183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally resolved membrane binding affinity of the N-terminus of α-synuclein.
    Robotta M; Hintze C; Schildknecht S; Zijlstra N; Jüngst C; Karreman C; Huber M; Leist M; Subramaniam V; Drescher M
    Biochemistry; 2012 May; 51(19):3960-2. PubMed ID: 22494024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein binds to the inner membrane of mitochondria in an α-helical conformation.
    Robotta M; Gerding HR; Vogel A; Hauser K; Schildknecht S; Karreman C; Leist M; Subramaniam V; Drescher M
    Chembiochem; 2014 Nov; 15(17):2499-502. PubMed ID: 25209675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein.
    Jo E; Fuller N; Rand RP; St George-Hyslop P; Fraser PE
    J Mol Biol; 2002 Jan; 315(4):799-807. PubMed ID: 11812148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Parkinson disease mutations influence α-synuclein assembly.
    Ono K; Ikeda T; Takasaki J; Yamada M
    Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Room-temperature in-cell EPR spectroscopy: alpha-Synuclein disease variants remain intrinsically disordered in the cell.
    Cattani J; Subramaniam V; Drescher M
    Phys Chem Chem Phys; 2017 Jul; 19(28):18147-18151. PubMed ID: 28696461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of alpha-synuclein and mutants with lipid membranes: spin-label ESR and polarized IR.
    Ramakrishnan M; Jensen PH; Marsh D
    Biochemistry; 2006 Mar; 45(10):3386-95. PubMed ID: 16519533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Parkinson's disease-linked mutations on the structure of lipid-associated alpha-synuclein.
    Bussell R; Eliezer D
    Biochemistry; 2004 Apr; 43(16):4810-8. PubMed ID: 15096050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation.
    Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-Terminal Cu
    Abeyawardhane DL; Heitger DR; Fernández RD; Forney AK; Lucas HR
    ACS Chem Neurosci; 2019 Mar; 10(3):1402-1410. PubMed ID: 30384594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.